In the first study of its kind, researchers at Saint LouisUniversity have demonstrated that immunization with a new vaccine could potentially prevent more than a million cases of pertussis (whooping cough) each year in adolescents and adults.
Most children are protected from pertussis by a series of vaccines in early childhood. But the vaccine protection wanes after a decade or so, leaving adolescents and adults susceptible to the bacterial infection.
“It’s a misconception that you’re protected from pertussis for life if you’ve been vaccinated as a child,” said Stephen J. Barenkamp, MD, professor of pediatrics and one of the study’s clinical investigators. He also is director of the Pediatric Research Institute at the Saint Louis University School of Medicine. “The study demonstrated that an estimated one in 300 adolescents and adults contracts the illness each year. The results also demonstrate that an effective vaccine is now available for this population and its use should be strongly encouraged.”
Barenkamp’s comments are based on results of a large, multi-center clinical study of more than 2,781 healthy adolescents and adults between the ages of 15 and 65. Barenkamp said approximately half the patients received a vaccine to protect against pertussis. The other half received a control vaccine. Researchers followed the patients for 2.5 years and determined that the pertussis vaccine was more than 90 percent effective in preventing the highly contagious illness.
Although pertussis is rarely life-threatening in adults, Barenkamp said the booster shot would not only prevent weeks of severe coughing, it hopefully would also prevent adults from spreading the infection to small children, for whom the disease can be deadly.
The Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices recently recommended that all 11- and 12-year-olds be given a dose of this new pertussis vaccine as a combined formulation with tetanus and diphtheria boosters. Recommendations for immunization of older adults are under active review.
Barenkamp said another purpose of the study was to gather data on the true incidence of pertussis in adolescents and adults. He said that underreporting of the illness is substantial because physicians often do not consider the possibility of pertussis when they treat adults for persistent cough. Complicating matters further, he said, the test used to detect pertussis in children is often not sensitive enough to detect pertussis in adults. Barenkamp said a test used during the study known as the pertussis polymerase chain reaction (PCR) assay is more sensitive and is becoming more widely available for testing of patients of all ages.
Study results were published in the Oct. 13, 2005 issue of the New England Journal of Medicine.
Other institutions that participated in the study include: the UCLA Center for Vaccine Research; University of Rochester; University of Pittsburgh School of Medicine; Children’s Hospital of Pittsburgh; Baylor College of Medicine; Cincinnati Children’s Hospital Medical Center; University of Maryland School of Medicine; Vanderbilt University Medical Center; and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
WASHINGTON, D.C. -- A new report by AARP's Public Policy Institute highlights the impact of low vaccination rates for influenza and pneumonia among older black and Hispanic populations. Rates for these groups lag significantly behind whites. Together, influenza and pneumonia represent the eighth leading cause of death in the United States, despite the availability of annual flu shots and the ...
The HPV vaccine, sold as Gardasil in the U.S., is intended to prevent four strains of the human papillomavirus, the most common sexually transmitted infection in the world. The vaccine also prevents against cervical cancer. While the vaccine represents a significant public health advance, a new article in the Journal of Law, Medicine & Ethics suggests that it is premature ...
BOSTON -- Most adults are not up to date on their vaccinations, says a new report from HarvardMedicalSchool. The report, “Viruses and Infectious Diseases,” describes how fast-adapting viruses pose an advancing threat to human health and urges adults to seek out new vaccines and renew their old ones. The new report explains how viruses and other infections affect the body, ...
WINSTON-SALEM, N.C. – A new study by researchers at Wake Forest University School of Medicine and Vanderbilt University suggests that protecting infants from a common, highly contagious and even deadly disease may be as easy as administering a routine vaccine two weeks earlier than it is typically given.The shift has the potential to prevent at least 1,236 cases of pertussis, ...
Influenza vaccination rates for adolescents who suffer from asthma and other illnesses are still far too low, according to a recent study. The research, published in the November 2008 issue of Pediatrics, was based at the Department of Ambulatory Care and Prevention at HarvardMedicalSchool and Harvard Pilgrim Health Care."Influenza vaccination has been recommended for adolescents with high-risk conditions for well ...
Bacteria and viruses are the microscopic organisms – otherwise known as germs -- that are responsible for causing and transmitting illness and disease. These microbes are so small, that according to the American Society for Microbiology, if the smallest of all microbes was the size of a baseball, an average bacterium would then be the size of the pitcher's mound, and just one of the millions of cells that make up your body would be the size of the ballpark!
